Latest Conference Articles

The benefits of naps for young children have been well established and utilized for many years. A recent study looked at whether taking a nap in the middle of the day could help hypertensive adults better manage their condition.

While PCSK9 inhibitors have been shown to help patients lower their cholesterol levels, there are still questions about potential side effects as well as when and how the medication will be made affordable and available to patients.

According to trial results presented at ESC Congress 2015, treatment with cyclosporine was no better than placebo for patients who received percutaneous coronary intervention for ST-segment elevation myocardial infarction.

It was less than two decades ago that researchers uncovered the role of PCSK9 in a person's body. In just the past few months two new medications have been developed that could go a long way in helping win the fight against bad cholesterol.

For some patients lifestyle intervention may not be enough to help them get the results they are looking for. Doctors are looking for more definitive treatments to assist their patients in the future.

By the time patients are treated by a cardiologist their condition has already made significant progress. Finding ways to treat them before they reach the specialist stage has become a focus of the medical community.

Not all emergency rooms are created equal, but if hospitals work together patients can still get the care they need even if it means going to another institution. Ensuring patients can afford the care they receive is also a key component to this discussion.

In an emergency room doctors sometimes only have a matter of moments to make the best diagnosis for a patient. Having the tools to make those calls is important in keeping their patients healthy and alive.

While the treatment of atrial fibrillation has made many advancements in recent years there is still much more work to be done. As with other areas of medicine this includes individualized approaches to care.

At the annual ESC Congress in London there were many key studies presented. Some of them could provide information that doctors can put into practice as soon as they return to the office.

Atrial fibrillation is a common condition cardiologists face on a regular basis. How best to treat those patients is an area still being worked on in the field and in practices around the world.

Patients with gastric ulcers are always looking for the fastest way to heal their conditions. A recent study looked at whether exercise in rats helped expedite the healing process.

While everyone has the fibroblast 23 hormone there has been some research into whether it can be linked to diseases and other conditions that can make some people sick.

While its base is the same as currently used tests for thyroid cancer a new approach is looking to redefine the specificity and exclusivity to help patients get a better idea of their condition.

Patients being tested for thyroid cancer want to know they are receiving the most accurate information possible following the test. A new method could help provide both answers for patients and direction for doctors about the best course of action.

Treatment for patients who are obese or overweight have seen significant improvements in treatment options over the past decade, but there is still much ore work to be done.

In a global community it can be just as important for doctors to remember where their patients come from as where they are now. Understanding different cultures can help provide care to all segments of the population.

Patients with chronic critical illness face a litany of health issues after their treatment needing care for these conditions. While pamidronate has been used in the past a new study looked at whether the treatment affects areas like bone absorption and overall mortality and ventilator liberation.

A considerable amount of progress has been made in treating diabetes this year both for type 1 and type 2 diabetes. The approval of new medications and potential devices in the future have made for a bright outlook for patients.

Fecal microbiota transplant has been used to treat patients with c-diff for a while now but one of the biggest questions is what else can it do. A recent study looked at using the procedure to remove antibiotic resistant genes.

Patients with C-Diff are being treated with fecal microbiota transplantation but there is still more research being done in the field to learn more about the potential benefits in the field.

Hormone therapy has proven a very effective option for many women during menopause but there has also been some evidence that it can increase the likelihood of bleeding disorders. A recent study looked at the link between the two.

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

Whether it is due to doctors waiting to make a diagnosis or patients waiting to see a doctor in the first place, diagnosis delay can be a considerable issue for patients with celiac disease. A recent study looked at just how big a problem this can be in the medical community.

With research of progressive multiple sclerosis lagging behind that of the relapsing form of the condition a group of the top minds from around the world is looking to speed up the process to help patients that need it most.

Patients coming out of surgery face a variety of risks even when the operation is done. A group is looking into a new device that can help with patients undergoing abdominal surgery to detect ileus after going under the knife.

The internet can be an endless source of information for patients looking to learn more about their conditions and possible treatments and surgical options. Whether those sources provide the help needed is another issue for healthcare professionals to tackle.

As hepatitis C becomes a curable condition in many parts of the world research is also showing the financial benefits of allowing once sick patients to resume their normal lives after treatment.

For patients who might need an intestinal transplant the surgery can often be a difficult and not always a permanent process. A new area of research is looking at whether cells can form intestines in the patients without needing the full transplant process.

As researchers look to learn more about drug induced liver injury sometimes looking at one patient alone cannot determine the potential causes of the condition. A recent preliminary study looked at what might be a "hidden pattern," to help patients.